Campath induction in renal transplantation
Kidney transplantation significantly improves quality of life and survival in patients with advanced renal failure and it has become the treatment of choice. Long-term immunosuppressants following transplantation are associated with an increased risk of infection, malignancy and diabetes. Therefore,...
Main Author: | Chan, Ka Kit |
---|---|
Other Authors: | Taube, David ; Lightstone, Liz |
Published: |
Imperial College London
2013
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.616789 |
Similar Items
-
The evolving role of alemtuzumab (Campath-1H) in renal transplantation
by: Phuong-Thu T Pham, et al.
Published: (2008-12-01) -
Long-lived immunomodulation following Campath-1H
by: Jones, Joanne Louise
Published: (2008) -
The effects of CAMPATH on cord blood and peripheral blood cells
by: Lee, F. Y.
Published: (2015) -
Antiidiotypic antibodies in renal transplantation
by: Al-Muzairai, Ibrahim Abdulaziz
Published: (1990) -
Blood transfusion and renal transplantation
by: Proud, G.
Published: (1980)